While the biosimulation leader reports rising revenues and capital investment, its key profitability metric—Return on Capital Employed—has declined to 2.2%, significantly trailing the healthcare services sector. Analysts question whether current growth investments will translate into future shareholder value.
Despite headwinds in the smartphone market, Bernstein remains constructive on Qualcomm (QCOM), citing its valuation discount, high-end market positioning, and growing AI narrative as key drivers for future performance.
While Veeva Systems continues to invest heavily in its future, a five-year slide in its return on capital employed (ROCE) signals potential headwinds for the life sciences cloud giant. We examine whether the current growth-at-all-costs strategy will pay off for long-term shareholders.
A new discounted cash flow analysis suggests Alnylam Pharmaceuticals (ALNY) shares trade at a significant discount to their intrinsic value, presenting a potential opportunity for investors. However, experts caution that valuation is just one piece of the investment puzzle.
Recent share price gains at Charter Communications have clawed back some losses for executives who bought $1.1 million in stock last year, though the group remains nearly a quarter-million dollars in the red. The mixed insider activity signals cautious optimism amid sector volatility.
Uber Technologies reported a mixed quarter, with strong trip growth driven by affordable options but at the cost of profit margins, leading to a disappointing forecast and a sharp premarket stock decline.
As tax season approaches, financial advisors are urging investors to look beyond basic filings. Strategic placement of assets, savvy use of specialized accounts, and timing transactions can significantly enhance after-tax returns over the long haul.
Skeena Resources has received the final Environmental Management Act permit for its Eskay Creek gold-silver project in British Columbia, completing the regulatory process and setting the stage for mining to resume in Q2 2027 following a collaborative approval with Indigenous partners.
As the largest generation in U.S. history approaches retirement, Federal Reserve data reveals a stark divide in preparedness, with millions lacking any dedicated savings and median balances that may not sustain decades of post-work life.
A new report from the influential CfC St. Moritz conference reveals a significant cooling in enthusiasm for crypto IPOs among wealthy investors and executives. While some activity is expected in 2026, confidence has dipped from last year's peak, with attention turning to liquidity, regulation, and market consolidation.
New research exposes a systemic flaw in cryptocurrency media, finding that most press releases distributed through specialized wires promote dubious projects, blurring the lines between news and unvetted marketing.
A deadly collision off the coast of Chios has left at least 15 migrants dead and sparked a major search operation, highlighting the ongoing perils of Mediterranean migration routes amid tightening EU policies.
Major health insurers face a dual regulatory assault as a proposed freeze on Medicare Advantage payments coincides with a new Department of Labor rule targeting opaque Pharmacy Benefit Manager (PBM) practices, threatening profits on both sides of their businesses.
As data center electricity demand is set to double by 2030, established energy providers like Dominion Energy are emerging as critical, lower-volatility beneficiaries of the artificial intelligence revolution.
Fugro has mobilized a significant fleet to conduct a comprehensive geotechnical survey for TotalEnergies' 2GW NordSee Energies 1 project, a key development in Germany's offshore wind expansion and Europe's push for energy security.
Medtronic has exercised its option to acquire CathWorks, the developer of the AI-powered FFRangio System, in a deal valued at $585 million. The acquisition, pending regulatory approval, aims to accelerate the transformation of coronary artery disease diagnosis and solidify Medtronic's position in the digital cath lab.
Novo Nordisk stock plummeted nearly 17% following a stark forecast predicting a significant drop in 2026 sales and profit, driven by intense U.S. price pressures and rising competition in the lucrative GLP-1 drug market.
Disney's latest animated juggernaut isn't just a theatrical hit; it's a case study in how the company leverages blockbuster IP to drive growth across streaming, parks, and consumer products, creating a competitive moat that rivals struggle to breach.
Amid a strong start for major indices, a look at three lesser-known companies where recent insider buying activity hints at underlying value and management confidence.
As major indices climb, a screen for undervalued stocks reveals potential opportunities in industrial power, regional banking, and consumer beverages, with discounts to fair value estimated as high as 49.6%.
